<DOC>
	<DOCNO>NCT01635738</DOCNO>
	<brief_summary>Many study demonstrate probiotic could apply prevention adjuvant treatment allergic disease . In study , investigate effect Lactobacillus paracasei GMNL-133 ( LP ) , Lactobacillus fermentum GM-090 ( LF ) , Lactobacillus paracasei GMNL-133 ( LP ) Lactobacillus fermentum GM-090 ( LF ) combination product use adjuvant treatment atopic dermatitis asthma .</brief_summary>
	<brief_title>Probiotics Allergic Diseases</brief_title>
	<detailed_description>The main purpose : To investigate Lactobacillus paracasei GMNL-133 ( LP ) , Lactobacillus fermentum GM-090 ( LF ) , Lactobacillus paracasei GMNL-133 ( LP ) Lactobacillus fermentum GM-090 ( LF ) combination product could use adjuvant treatment atopic dermatitis asthma . The Secondary Objective : To investigate whether probiotic consumption improve quality life allergic symptom different people Lactobacillus paracasei GMNL-133 ( LP ) , Lactobacillus fermentum GM-090 ( LF ) Lactobacillus paracasei GMNL-133 ( LP ) Lactobacillus fermentum GM-090 ( LF ) combination product .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>1 . Age 1 year old 18 year old , 2 . AD case fulfill diagnostic criterion Hannifin Rajka . 3 . Atopy show least one positive skin test ( weal size ≧ 3mm ) one positive MAST ( RAST ) ( IgE ≧ 0.7 kU/L ) test common food environmental allergen . 1 . Systematic corticosteroid , immunosuppressive therapy , antimycotic treatment 4 week , antihistamine , singulair 7 day enrollment 2 . Probiotic preparation use within 2 week enter study 3 . Use antibiotics oral medication interfere result 4 . If immune deficiency disease major medical problem 5 . If participate another clinical study past month . 6 . Subjects undergoing desensitization therapy within 3 month prior screen period . 7 . Subjects participate investigational drug trial within 4 week enter study . 8 . Subjects pregnant , lactate plan become pregnant . 9 . Subjects serious disease consider investigator could interfere performance SCORAD score result . 10 . Subjects lack physical integrity gastrointestinal tract , malabsorption syndrome , inability take oral medication .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Probiotics</keyword>
	<keyword>Lactobacillus paracasei GMNL-133</keyword>
	<keyword>Lactobacillus fermentum GM-090</keyword>
	<keyword>Atopic dermatitis</keyword>
	<keyword>Asthma</keyword>
	<keyword>Lactobacillus paracasei</keyword>
	<keyword>Lactobacillus fermentum</keyword>
	<keyword>efficacy safety</keyword>
</DOC>